Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Medtronic
McKesson
Dow
Johnson and Johnson
Harvard Business School
Mallinckrodt

Last Updated: December 16, 2019

DrugPatentWatch Database Preview

METHYLPREDNISOLONE SODIUM SUCCINATE Drug Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

When do Methylprednisolone Sodium Succinate patents expire, and when can generic versions of Methylprednisolone Sodium Succinate launch?

Methylprednisolone Sodium Succinate is a drug marketed by Abraxis Pharm, Amneal Pharms Co, Aurobindo Pharma Ltd, Bedford Labs, Elkins Sinn, Fresenius Kabi Usa, Hikma, Intl Medication, Sagent Pharms Inc, Teva Parenteral, and Watson Labs. and is included in thirty-one NDAs.

The generic ingredient in METHYLPREDNISOLONE SODIUM SUCCINATE is methylprednisolone sodium succinate. There are forty drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the methylprednisolone sodium succinate profile page.

US ANDA Litigation and Generic Entry Outlook for Methylprednisolone Sodium Succinate

A generic version of METHYLPREDNISOLONE SODIUM SUCCINATE was launched as methylprednisolone sodium succinate by FRESENIUS KABI USA on December 16th, 2019.

Summary for METHYLPREDNISOLONE SODIUM SUCCINATE
Drug patent expirations by year for METHYLPREDNISOLONE SODIUM SUCCINATE
Recent Clinical Trials for METHYLPREDNISOLONE SODIUM SUCCINATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Children's Hospital of Fudan UniversityPhase 3
Taipei Medical University WanFang HospitalPhase 2/Phase 3
Azienda Policlinico Umberto IPhase 3

See all METHYLPREDNISOLONE SODIUM SUCCINATE clinical trials

Pharmacology for METHYLPREDNISOLONE SODIUM SUCCINATE
Synonyms for METHYLPREDNISOLONE SODIUM SUCCINATE
(2R)-2-Mercaptomethyl-4-methylpentanoyl-Phe-Ala amide
(6alpha,11beta)-21-(3-Carboxy-1-oxopropoxy)-11,17-dihydroxy-6-methyl-Pregna-1,4-diene-3,20-dione monosodium salt
1,4-pregnadien-6-alpha-methyl-11-beta, 17,21-triol-3,20-dione 21-succinate, sodium salt
11-beta,17,21-Trihydroxy-6-alpha-methyl-1,4-pregnadiene-3,20-dione 21-(sodium succinate)
11-beta,17,21-trihydroxy-6-alpha-methyl-1,4-pregnadiene-3,20-dione21-(sodium
11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione 21-(hydrogen succinate)
11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione 21-(sodium succinate)
2375-03-3
2375-03-3 (mono-hydrochloride salt)
2921-57-5
2921-57-5 (Parent)
375M033
4-(2-((6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethoxy)-4-oxobutanoic acid
4-[2-(11,17-dihydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl)-2-oxoethoxy]-4-oxobutanoate
4-[2-[(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethoxy]-4-oxobutanoic acid
4-oxidanylidene-4-[2-oxidanylidene-2-[(6S,8S,9S,10R,11S,13S,14S,17R)-6,10,13-trimethyl-11,17-bis(oxidanyl)-3-oxidanylidene-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]ethoxy]butanoic acid
5GMR90S4KN
6-alpha-Methylprednisolone sodium succinate
6-Methylprednisolone 21-hemisuccinate sodium salt
6.alpha.-Methylprednisolone 21-hemisuccinate sodium salt
6.alpha.-Methylprednisolone 21-sodium hemisuccinate
6.alpha.-Methylprednisolone 21-sodium succinate
6.alpha.-Methylprednisolone sodium hemisuccinate
6.alpha.-Methylprednisolone sodium succinate
6.alpha.-Methylpregnisolone 21-sodium succinate
6|A-Methyl-11|A,17|A,21-trihydroxy-1,4-pregnadiene-3,20-dione 21-hemisuccinate
6|A-Methylprednisolone 21-hemisuccinate (sodium salt)
6|A-Methylprednisolone 21-hemisuccinate Sodium
6|A-Methylprednisolone 21-hemisuccinate sodium salt
6A-methylprednisolone 21-hemisuccinate*sodium
6a-Methylprednisolone 21-succinate sodium
6AfAE'A centa' notA inverted exclamation markAfasA'A|AfAE'Adaggeratrade mark?-Methylprednisolone 21-hemisuccinate (sodium salt)
6alpha-Methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione 21-hemisuccinate
6alpha-methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione 21-hemisuccinate sodium salt
6alpha-Methylprednisolone 21-hemisuccinate
6alpha-Methylprednisolone 21-hemisuccinate sodium salt
6alpha-Methylprednisolone 21-hemisuccinate sodium salt, lyophilized powder
6alpha-Methylprednisolone 21-sodium hemisuccinate
6alpha-Methylprednisolone 21-sodium succinate
6alpha-Methylprednisolone hemisuccinate
6alpha-Methylprednisolone sodium hemisuccinate
6alpha-Methylprednisolone sodium succinate
6alpha-Methylpregnisolone 21-sodium succinate
6I+/--Methylprednisolone 21-hemisuccinate sodium salt
921M575
A-methapred (TN)
A819819
AB00053696_02
AC1L28YL
AC1NO89B
AJ-47556
AK-94859
AKOS015894899
AKOS015962276
AKOS016011114
AN-14230
Asmacortone
AX8105809
C-22742
C26H33O8.Na
C26H34O8
CAS-2375-03-3
CCG-213144
CHEBI:135765
CHEBI:6890
CHEMBL1201081
CHEMBL1201265
Corticel
Cryosolona
Cryosolona [inj.]
CS-4582
CS-8183
CTK8G1090
D00751
D05000
DSSTox_CID_3303
DSSTox_GSID_23303
DSSTox_RID_76967
DTXSID2023303
DTXSID80183466
EC 220-863-9
EINECS 219-156-8
EINECS 220-863-9
Emmetipi
Firmacort Fiale
FQISKWAFAHGMGT-SGJOWKDISA-M
HMS2093A09
HY-B1060
HY-B1900
I038
LEC9GKY20K
Lemod Solu
LS-118430
LS-118507
M-6-P
Medrate [inj.]
Meghylprednisolone hemisuccinate
methprednisolone sodium succinate
Methylprednisolone 21-(hydrogen succinate)
METHYLPREDNISOLONE HEMISUCCINATE
Methylprednisolone hemisuccinate (USP)
Methylprednisolone Hemisuccinate [USP]
Methylprednisolone Hemisuccinate Monosodium Salt
Methylprednisolone hydrogen succinate
Methylprednisolone Hydrogen Succinate Sodium Salt
Methylprednisolone sodium hemisuccinate
Methylprednisolone sodium succinate (JAN/USP)
Methylprednisolone Sodium Succinate (methylprednisolone 21-(hydrogen succinate))
Methylprednisolone Sodium Succinate [USAN:JAN]
Methylprednisolone sodium succinate [USP:JAN]
Methylprednisolone succinate
Methylprednisolone succinate (JP17)
Methylprednisolone succinate sodium salt
Metypred
Metypred [inj.]
Metypresol
MFCD00152612
MolPort-005-935-240
MolPort-006-114-238
NCGC00185763-01
Nirypan solubile
NSC 48989
NSC-48989
NSC-758428
NSC48989
NSC758428
Omnacortil
Pharmakon1600-01503255
Prednilem
Prednisolone, 6alpha-methyl-, succinate, sodium salt
Prednisolone, succinate, sodium salt
Prednol
Prednol [inj.]
Pregna-1,20-dione, 11.beta.,17,21-trihydroxy-6.alpha.-methyl-, 21-(hydrogen succinate), monosodium salt
Pregna-1,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-6-methyl-, monosodium salt, (6.alpha.,11.beta.)-
Pregna-1,4-diene-3,20-dione, 11-beta,17,21-trihydroxy-6-alpha-methyl-, 21- (hydrogen succinate), monosodium salt
Pregna-1,4-diene-3,20-dione, 11-beta,17,21-trihydroxy-6-alpha-methyl-, 21-(hydrogen succinate), monosodium salt
Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl-, 21-(hydrogen succinate), monosodium salt
Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl-, 21-(hydrogen succinate), monosodium salt (8CI)
Pregna-1,4-diene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-6-methyl-, (6alpha,11beta)-
Pregna-1,4-diene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-6-methyl-, monosodium salt, (6alpha,11beta)-
Pregna-1,4-diene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-6-methyl-,(6-alpha,11-beta)-
Pregna-1,4-diene-3,20-dione,21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-6-methyl-, (6a,11b)-
SCHEMBL40947
SCHEMBL7915
sodium 4-[2-[(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxo-ethoxy]-4-oxo-butanoate
sodium 4-{[(6alpha,11beta)-11,17-dihydroxy-6-methyl-3,20-dioxopregna-1,4-dien-21-yl]oxy}-4-oxobutanoate
Sodium methylprednisolone succinate
sodium;4-[2-[(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethoxy]-4-oxobutanoate
Sol Melcort
Solu Medrol
Solu-Medrol
Solu-medrol (TN)
Solu-Medrone
Solumedrol
SR-05000002140
SR-05000002140-1
Succinic acid, 21-monoester with 11beta,17,21-trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione, monosodium salt
Tox21_113527
U 9088
Ubrason solubile
Ubrason solubile [inj.]
UNII-5GMR90S4KN
UNII-LEC9GKY20K
Urabason
Urbason solubile
Urbason-Soluble
W-107376
ZINC3977781

US Patents and Regulatory Information for METHYLPREDNISOLONE SODIUM SUCCINATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs METHYLPREDNISOLONE SODIUM SUCCINATE methylprednisolone sodium succinate INJECTABLE;INJECTION 088524-001 Jul 24, 1984 DISCN No No   Start Trial   Start Trial   Start Trial
Intl Medication METHYLPREDNISOLONE SODIUM SUCCINATE methylprednisolone sodium succinate INJECTABLE;INJECTION 087851-001 Feb 9, 1983 DISCN No No   Start Trial   Start Trial   Start Trial
Hikma METHYLPREDNISOLONE SODIUM SUCCINATE methylprednisolone sodium succinate INJECTABLE;INJECTION 202691-001 Feb 16, 2016 AP RX No No   Start Trial   Start Trial   Start Trial
Sagent Pharms Inc METHYLPREDNISOLONE SODIUM SUCCINATE methylprednisolone sodium succinate INJECTABLE;INJECTION 040888-004 Jul 18, 2011 AP RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Dow
Mallinckrodt
Merck
Boehringer Ingelheim
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.